CATEGORIES

Medication

LATEST

TRENDING

EDITORS CHOICE

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

FDA Approval of New Drug for Alzheimer’s Offers Hope

The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

How Suboxone Set Me Free From Opiate Addiction

A pregnant patient shares her journey to overcome opiate addiction to hydrocodone by starting Suboxone.

Exponential Innovation: Disrupting The Disruptor

Today's world of disruptive change is defined by two terms: innovation and speed.  The big idea is important, but equally so is the path that innovation...